Glycosylation is one of the main IgG post-translational modifications and has essential roles in antibody effectors functions, immunogenicity and plasmatic clearance. In this chapter we discuss and provide detailed protocols for IgG homogeneity and determination of level of glycosylation by Capillary Electrophoresis-Sodium Dodecyl Sulfate (CE-SDS), for orthogonal glyco-profiling of IgG-released glycans by Capillary Electrophoresis with a Laser-Induced Fluorescent Detector (CE-LIF) and by Normal-Phase High Performance Liquid Chromatography (NP-HPLC), as well as glycans fine structure assessment by Matrix-Assisted Laser Desorption/ Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) and by nano-Liquid Chromatography tandem mass spectrometry fragmentation (nano-LC-MS/MS).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arnold JN, Royle L, Dwek RA, Rudd PM, Sim RB (2005) Human immunoglobulin glycosylation and the lectin pathway of complement activation. Adv Exp Med Biol 564:27–43
Bakker H, Rouwendal GJA, Karnoup AS, Florack DEA, Stoopen GM, Helsper JPFG, Van Ree R, Van Die I, Bosch D (2006) An antibody produced in tobacco expressing a hybrid β-1, 4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci USA 103:7577–7582
Beck A, Bussat MC, Zorn N, Robillard V, Klinguer-Hamour C, Chenu S, Goetsch L, Corvaia N, Van Dorsselaer A, Haeuw JF (2005) Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. J Chromatogr B Analyt Technol Biomed Life Sci 819:203–218
Beck A, Klinguer-Hamour C, Bussat MC, Champion T, Haeuw JF, Goetsch L, Wurch T, Sugawara M, Milon A, Van Dorsselaer A, Nguyen T, Corvaia N (2007) Peptides as tools and drugs for immunotherapies. J Pept Sci 13:588–602
Beck A, Wagner-Rousset E, Bussat MC, Lokteff M, Klinguer-Hamour C, Haeuw JF, Goetsch L, Wurch T, Van Dorsselaer A, Corvaia N (2008a) Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins. Curr Pharm Biotechnol 9:482–501
Beck A, Wurch T, Corvaïa N (2008b) Editorial: therapeutic antibodies and derivatives: from the bench to the clinic. Curr Pharm Biotechnol 9:421–422
Beck A, Wagner-Rousset E, Goetsch L, Corvaïa N (2008c) Therapeutic antibodies: structure assessment by mass spectrometry from screening to clinical batches. Screen Trends Drug Discov 9:18–20
Birch JR, Racher AJ (2006) Antibody production. Adv Drug Deliv Rev 58:671–685
Butler M (2005) Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68:283–291
Chartrain M, Chu L (2008) Development and production of commercial therapeutic monoclonal antibodies in mammalian cell expression system: an overview of the current upstream technologies. Curr Pharm Biotechnol 9:447–467
Chelius D, Huff Wimer ME, Bondarenko PV (2006) Reversed-phase liquid chromatography in-line with negative ionization electrospray mass spectrometry for the characterization of the disulfide-linkages of an immunoglobulin gamma antibody. J Am Soc Mass Spectrom 17:1590–1598
Chen X, Tang K, Lee M, Flynn GC (2008) Microchip assays for screening monoclonal antibody product quality. Electrophoresis 29:4993–5002
Echelard Y, Ziomek CA, Meade HM (2006) Production of recombinant therapeutic proteins in the milk of transgenic animals. BioPharm Int 19:36–46
Ferrara C, Brunker P, Suter T, Moser S, Puntener U, Umana P (2006) Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. Biotechnol Bioeng 93:851–861
Forrer K, Hammer S, Helk B (2004) Chip-based gel electrophoresis method for the quantification of half-antibody species in IgG4 and their by- and degradation products. Anal Biochem 334:81–88
Gadgil HS, Pipes GD, Dillon TM, Treuheit MJ, Bondarenko PV (2006) Improving mass accuracy of high performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of intact antibodies. J Am Soc Mass Spectrom 17:867–872
Gennaro LA, Salas-Solano O. (2008) On-Line CE-LIF-MS Technology for the Direct Characterization of N-Linked Glycans from Therapeutic Antibodies. Analytical Chemistry (in press)
Gomord V, Chamberlain P, Jefferis R, Faye L (2005) Biopharmaceutical production in plants: problems, solutions and opportunities. Trends Biotechnol 23:559–565
Guile GR, Rudd PM, Wing DR, Prime SB, Dwek RA (1996) A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem 240:210–226
Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, Bobrowicz P, Stadheim TA, Li H, Choi BK, Hopkins D, Wischnewski H, Roser J, Mitchell T, Strawbridge RR, Hoopes J, Wildt S, Gerngross TU (2006) Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 313:1441–1443
Hinton PR, Xiong JM, Johlfs MG, Tang MT, Keller S, Tsurushita N (2006) An engineered human IgG1 antibody with longer serum half-life. J Immunol 176:346–356
Hodoniczky J, Zheng YZ, James DC (2005) Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog 21:1644–1652
Holland M, Yagi H, Takahashi N, Kato K, Savage COS, Goodall DM, Jefferis R (2006) Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta Gen Subj 1760:669–677
Huang LH, Biolsi S, Bales KR, Kuchibhotla U (2006) Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. Anal Biochem 349:197–207
Jefferis R (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21:11–16
Jefferis R (2006) Criteria for selection of IgG isotype and glycoform of antibody therapeutics. BioProcess Int 4:40–43
Jones D, Kroos N, Anema R, van Montfort B, Vooys A, van Der KS, van Der HE, Smits S, Schouten J, Brouwer K, Lagerwerf F, van Berkel P, Opstelten DJ, Logtenberg T, Bout A (2003) High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 19:163–168
Kamoda S, Kakehi K (2006) Capillary electrophoresis for the analysis of glycoprotein pharmaceuticals. Electrophoresis 27:2495–2504
Kamoda S, Kakehi K (2008) Evaluation of glycosylation for quality assurance of antibody pharmaceuticals by capillary electrophoresis. Electrophoresis 29:3595–3604
Kamoda S, Ishikawa R, Kakehi K (2006) Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies. J Chromatogr A 1133:332–339
Kanda Y, Yamane-Ohnuki N, Sakai N, Yamano K, Nakano R, Inoue M, Misaka H, Iida S, Wakitani M, Konno Y, Yano K, Shitara K, Hosoi S, Satoh M (2006) Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC. Biotechnol Bioeng 94:680–688
Kost TA, Condreay JP, Jarvis DL (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23:567–575
Li H, Sethuraman N, Stadheim TA, Zha D, Prinz B, Ballew N, Bobrowicz P, Choi BK, Cook WJ, Cukan M, Houston-Cummings NR, Davidson R, Gong B, Hamilton SR, Hoopes JP, Jiang Y, Kim N, Mansfield R, Nett JH, Rios S, Strawbridge R, Wildt S, Gerngross TU (2006) Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat Biotechnol 24:210–215
Lobo ED, Hansen RJ, Balthasar JP (2004) Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 93:2645–2668
Prater BD, Connelly HM, Qin Q, Cockrill SL (2009) High-throughput immunoglobulin G N-glycan characterization using rapid resolution reverse-phase chromatography tandem mass spectrometry. Anal Biochem 385:69–79
Raju TS, Scallon BJ (2006) Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain. Biochem Biophys Res Commun 341:797–803
Rehder DS, Dillon TM, Pipes GD, Bondarenko PV (2006) Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics. J Chromatogr A 1102:164–175
Rustandi RR, Washabaugh MW, Wang Y (2008) Applications of CE SDS gel in development of biopharmaceutical antibody-based products. Electrophoresis 29:3612–3620
Sheeley DM, Merrill BM, Taylor LC (1997) Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. Anal Biochem 247:102–110
Suzuki N, Lee YC (2004) Site-specific N-glycosylation of chicken serum IgG. Glycobiology 14:275–292
Takegawa Y, Deguchi K, Keira T, Ito H, Nakagawa H, Nishimura S (2006) Separation of isomeric 2-aminopyridine derivatized N-glycans and N-glycopeptides of human serum immunoglobulin G by using a zwitterionic type of hydrophilic-interaction chromatography. J Chromatogr A 1113:177–181
Wagner-Rousset E, Bednarczyk A, Bussat MC, Colas O, Corvaia N, Schaeffer C, Van Dorsselaer A, Beck A (2008) The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies. J Chromatogr B Analyt Technol Biomed Life Sci 872:23–37
Walsh G, Jefferis R (2006) Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 24:1241–1252
Wildt S, Gerngross TU (2005) The humanization of N-glycosylation pathways in yeast. Nat Rev Microbiol 3:119–128
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this protocol
Cite this protocol
Janin-Bussat, MC., Wagner-Rousset, E., Klinguer-Hamour, C., Corvaia, N., van Dorsselaer, A., Beck, A. (2010). Antibody Glycans Characterization. In: Kontermann, R., Dübel, S. (eds) Antibody Engineering. Springer Protocols Handbooks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01144-3_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-01144-3_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01143-6
Online ISBN: 978-3-642-01144-3
eBook Packages: Springer Protocols